Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000318306-13-000012
Filing Date
2013-05-15
Accepted
2013-05-15 16:44:47
Documents
11
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10Q a10q-033113.htm 10-Q 515650
2 CEO CERTIFICATION ex_31-1.htm EX-31.1 16172
3 CFO CERTIFICATION ex_31-2.htm EX-31.2 16253
4 CEO CERTIFICATION ex_32-1.htm EX-32.1 5996
5 CFO CERTIFICATION ex_32-2.htm EX-32.2 6192
  Complete submission text file 0000318306-13-000012.txt   2433391

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE REPORT accp-20130331.xml EX-101.INS 271512
7 XBRL TAXONOMY SCHEMA accp-20130331.xsd EX-101.SCH 15372
8 XBRL TAXONOMY CALCULATION LINKBASE accp-20130331_cal.xml EX-101.CAL 35886
9 XBRL TAXONOMY DEFINITION LINKBASE accp-20130331_def.xml EX-101.DEF 80032
10 XBRL TAXONOMY LABEL LINKBASE accp-20130331_lab.xml EX-101.LAB 218480
11 XBRL TAXONOMY PRESENTATION LINKBASE accp-20130331_pre.xml EX-101.PRE 142870
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1025
Type: 10-Q | Act: 34 | File No.: 001-15771 | Film No.: 13847912
SIC: 2834 Pharmaceutical Preparations